Literature DB >> 3629873

Monensin and the control of experimental ovine toxoplasmosis: a systemic effect.

D Buxton, K M Donald, J Finlayson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3629873     DOI： 10.1136/vr.120.26.618

Source DB:  PubMed          Journal:  Vet Rec        ISSN： 0042-4900            Impact factor:   2.695


× No keyword cloud information.
  4 in total

1.  Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy.

Authors:  Roberto Sánchez-Sánchez; Ignacio Ferre; Michela Re; Juan José Ramos; Javier Regidor-Cerrillo; Manuel Pizarro Díaz; Marta González-Huecas; Enrique Tabanera; Julio Benavides; Andrew Hemphill; Matthew A Hulverson; Lynn K Barrett; Ryan Choi; Grant R Whitman; Kayode K Ojo; Wesley C Van Voorhis; Luis Miguel Ortega-Mora
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

2.  Disruption of a mitochondrial MutS DNA repair enzyme homologue confers drug resistance in the parasite Toxoplasma gondii.

Authors:  Erin M Garrison; Gustavo Arrizabalaga
Journal:  Mol Microbiol       Date:  2009-03-04       Impact factor: 3.501

Review 3.  Ovine toxoplasmosis: a review.

Authors:  D Buxton
Journal:  J R Soc Med       Date:  1990-08       Impact factor: 18.000

4.  Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function.

Authors:  Robert A Charvat; Gustavo Arrizabalaga
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.